PPARG and sarcoidosis: Mice receiving rosiglitazone had lower MWCNT-induced pulmonary granulomas in association with a reduced pro-inflammatory response, and sustained ABCG1 expression in macrophages, supporting the concept that PPARγ deficiency could play a role in sarcoidosis pathogenesis [150].